MedTrace Logo

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

NCT07754175 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2026-08-10

No results posted yet for this study

Summary

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Conditions

Sponsors & Collaborators

  • Kang Stem Biotech Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Kyoung Ho Yoon, professor (CI) · Kyung Hee University Hospital

  • Sang Hak Lee, professor · Gangdong Kyunghee University Hospital

  • Jang Ki Mo, professor · Korea University Anam Hospital

  • Sang Gyun Kim, professor · National medical center

  • Seok jung Kim, professor · The Catholic University of Korea, Uijeongbu St. Mary's Hospital

  • Jae Young Park, professor · CHA University Bundang Medical Center

  • Sung Hwan Kim, professor · Severance Hospital, Yonsei University College of Medicine

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-20
Primary Completion
2031-12-31
Completion
2032-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07754175 on ClinicalTrials.gov